Trial intelligence / Profile preview

RTS,S/AS02A Malaria Vaccine in Mozambican Children

NCT00197041Phase 2Completed

Sponsor
GSK
Start
Jul 2003
Primary completion
Apr 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Jul 2003; status: completed.

02

Drugs

RTS,S
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00197041.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00197041.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call